Clinical Trial Update: Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study [Phase 2]

View source ↗

Summary

This document describes a randomized Phase II clinical trial evaluating intracavitary carrier-embedded Cesium-131 brachytherapy for recurrent brain metastases. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Cesium-131 brachytherapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Recurrent Brain Metastases | Phase 2 | Status: RECRUITING